Headlands Technologies LLC Trims Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Headlands Technologies LLC lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 34.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,306 shares of the biotechnology company’s stock after selling 1,236 shares during the period. Headlands Technologies LLC’s holdings in Axon Enterprise were worth $596,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the business. Sands Capital Management LLC grew its position in shares of Axon Enterprise by 31.1% in the third quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock valued at $519,823,000 after purchasing an additional 619,179 shares during the period. Westfield Capital Management Co. LP grew its position in shares of Axon Enterprise by 184.3% in the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after purchasing an additional 451,350 shares during the period. Polar Capital Holdings Plc grew its position in shares of Axon Enterprise by 292.0% in the third quarter. Polar Capital Holdings Plc now owns 265,464 shares of the biotechnology company’s stock valued at $52,825,000 after purchasing an additional 197,746 shares during the period. Bank of New York Mellon Corp grew its position in shares of Axon Enterprise by 28.3% in the third quarter. Bank of New York Mellon Corp now owns 726,400 shares of the biotechnology company’s stock valued at $144,546,000 after purchasing an additional 160,359 shares during the period. Finally, International Assets Investment Management LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at about $39,907,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on AXON. JMP Securities lifted their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 6th. StockNews.com lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. Barclays boosted their price target on shares of Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a research report on Thursday, February 29th. TheStreet lowered shares of Axon Enterprise from a “b” rating to a “c+” rating in a research report on Tuesday, February 27th. Finally, Morgan Stanley boosted their price target on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $314.91.

Axon Enterprise Trading Up 0.6 %

AXON stock traded up $1.99 during trading on Friday, reaching $308.23. 300,741 shares of the stock were exchanged, compared to its average volume of 413,361. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The business has a 50 day moving average price of $303.45 and a 200-day moving average price of $260.90. Axon Enterprise, Inc. has a 1 year low of $175.37 and a 1 year high of $329.87. The firm has a market capitalization of $23.26 billion, a price-to-earnings ratio of 134.01 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.29. The business had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. On average, research analysts predict that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.